1378868-38-2

Basic information

• Product Name: (4-((N-(3-carbamoyl-5-cyclopropyl-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-6-yl)methylsulfonamido)methyl)-2-chlorophenyl)boronic acid
• Synonyms: (4-((N-(3-carbamoyl-5-cyclopropyl-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-6-yl)methylsulfonamido)methyl)-2-chlorophenyl)boronic acid
• CAS NO: 1378868-38-2
• Molecular Weight: 556.81
• Mol File: 1378868-38-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4-((N-(3-carbamoyl-5-cyclopropyl-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-6-yl)methylsulfonamido)methyl)-2-chlorophenyl)boronic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (4-((N-(3-carbamoyl-5-cyclopropyl-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-6-yl)methylsulfonamido)methyl)-2-chlorophenyl)boronic acid(1378868-38-2)
• EPA Substance Registry System: (4-((N-(3-carbamoyl-5-cyclopropyl-2-(4-fluorophenyl)pyrazolo[1,5-a]pyridin-6-yl)methylsulfonamido)methyl)-2-chlorophenyl)boronic acid(1378868-38-2)

Safety Data

• Hazardous Substances Data: 1378868-38-2(Hazardous Substances Data)

Upstream product

• 1378869-06-7 5-cyclopropyl-2-(4-fluorophenyl)-6-(N-(4-methoxybenzyl)methylsulfonamido)pyrazolo[1,5-a]pyridine-3-carboxylic acid 
• 1378869-05-6 ethyl 5-cyclopropyl-2-(4-fluorophenyl)-6-(N-(4-methoxybenzyl)methylsulfonamido)pyrazolo[1,5-a]pyridine-3-carboxylate 
• 1378869-03-4 1-amino-4-cyclopropyl-3-(N-(4-methoxybenzyl)methylsulfonamido)pyridinium 
• 1378869-02-3 N-(4-cyclopropylpyridin-3-yl)-N-(4-methoxybenzyl)methanesulfonamide 
• 68120-44-5 1-bromo-4-(bromomethyl)-2-chloro-benzene 
• 456-22-4 4-Fluorobenzoic acid 
• 1736-31-8 ethyl 3-(4-fluorophenyl)propiolate 
• 13091-23-1 4-chloro-3-nitropyridine 
• 120077-68-1 (4-bromo-3-chlorophenyl)methanol 
• 120077-67-0 4-bromo-3-chlorobenzoic acid ethyl ester 
• 25118-59-6 4-bromo-3-chlorobenzoic acid 
• 403-43-0 4-fluorobenzoyl chloride 
• 1378869-01-2 N-(4-cyclopropylpyridin-3-yl)methanesulfonamide 
• 1378869-00-1 N-(4-cyclopropylpyridin-3-yl)-N-(methylsulfonyl)methanesulfonamide 

Relevant articles and documents

COMPOUNDS

The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.